Effective and timely innovation of vaccines, diagnostics, and antivirals to respond to outbreaks of emerging infectious diseases is dependent on the efficient collaboration between scientists, governments, and companies. Such collaboration is not always self-evident, however. What can we learn from earlier outbreaks on innovation barriers and approaches to remedy them? And what role can technology play in facilitating this?
HOSTED BY DR. LINDA VAN DE BURGWAL AND PROF. DR. ERIC CLAASSEN
Webinar series Athena insitute